A new study in mice by scientists at Boise State University and Cognigenics, both in Idaho, demonstrates that a novel CRISPR/Cas9 genome-editing delivery system can bypass the blood–brain barrier and regulate neuronal receptor pathways, to treat chronic anxiety.
The findings are published in PNAS Nexus.
